Jon Hamilton

Solano-Garcia began going in for monthly infusions, which she didn't mind, and mental tests, which she found frustrating.

Solano-Garcia began going in for monthly infusions, which she didn't mind, and mental tests, which she found frustrating.

The drug didn't restore her memory, but after four years of treatment, she wasn't getting worse, at least not very quickly. So was the drug working? Not necessarily, says Dr. Lon Schneider, who directs the Alzheimer's Center at USC.

The drug didn't restore her memory, but after four years of treatment, she wasn't getting worse, at least not very quickly. So was the drug working? Not necessarily, says Dr. Lon Schneider, who directs the Alzheimer's Center at USC.

The drug didn't restore her memory, but after four years of treatment, she wasn't getting worse, at least not very quickly. So was the drug working? Not necessarily, says Dr. Lon Schneider, who directs the Alzheimer's Center at USC.

Schneider says what is clear is that after a year or more on kasunla, the beta amyloid plaques in a patient's brain are usually down to normal levels. He says that's led to a new approach with this drug, which was approved in 2024.

Schneider says what is clear is that after a year or more on kasunla, the beta amyloid plaques in a patient's brain are usually down to normal levels. He says that's led to a new approach with this drug, which was approved in 2024.

Schneider says what is clear is that after a year or more on kasunla, the beta amyloid plaques in a patient's brain are usually down to normal levels. He says that's led to a new approach with this drug, which was approved in 2024.

Schneider says at USC, doctors have a weekly meeting to discuss, among other things, which patients are candidates to stop taking Kisunla. Solana Garcia says she's one of those patients.

Schneider says at USC, doctors have a weekly meeting to discuss, among other things, which patients are candidates to stop taking Kisunla. Solana Garcia says she's one of those patients.

Schneider says at USC, doctors have a weekly meeting to discuss, among other things, which patients are candidates to stop taking Kisunla. Solana Garcia says she's one of those patients.

But hardly a cure. Solana Garcia remains unable to return to her fundraising career. And she has lost much of her command of the piano. So she maintains her house, volunteers with the Alzheimer's Association, and every week she visits a local memory care unit to sing.

But hardly a cure. Solana Garcia remains unable to return to her fundraising career. And she has lost much of her command of the piano. So she maintains her house, volunteers with the Alzheimer's Association, and every week she visits a local memory care unit to sing.

But hardly a cure. Solana Garcia remains unable to return to her fundraising career. And she has lost much of her command of the piano. So she maintains her house, volunteers with the Alzheimer's Association, and every week she visits a local memory care unit to sing.

Solana Garcia says she's learned a lot from the residents of the unit, most of whom have advanced Alzheimer's.

Solana Garcia says she's learned a lot from the residents of the unit, most of whom have advanced Alzheimer's.

Solana Garcia says she's learned a lot from the residents of the unit, most of whom have advanced Alzheimer's.

It was my pleasure.

It was my pleasure.

It was my pleasure.